Navigation Links
Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
Date:10/22/2007

PASADENA, Calif., Oct. 22 /PRNewswire/ -- Maven Biotechnologies, LLC, an early stage biotechnology company developing a label-free multiplexing immunodiagnostic analysis system, today announced that the company will deliver a presentation at the BIOCOM Investor Conference in San Diego, California. Jeffrey C. Travis, Ph.D., Maven's President and COO, will present on Thursday, November 1, 2007 at 3:30 PM.

About Maven Biotechnologies

Maven Biotechnologies, LLC has developed LFIRE(TM) (Label-Free Internal Reflection Ellipsometry) which is a complete diagnostics analysis system (instruments and disposables) that provides a next generation replacement measurement technology with significant cost benefits to the healthcare sector and technology improvements for the combined $15 B w/w immunodiagnostic markets. It offers the potential advantages of 50-75% reduced costs to both the diagnostics manufacturers and the clinical or pharma lab user. In addition, its breakthrough new way to measure immunodiagnostic tests more rapidly will positively impact point-of-care (POC) tests for emergency room screening (e.g. cardiac markers, drugs of abuse, etc.), at patient bedside, and in the O.R. Finally, it uniquely permits single to high density label-free multiplexing -- that is, when one to large numbers of tests per patient can be run at one time (e.g. tumor markers, autoimmune panels, etc.), greatly reducing costs for the patients, healthcare provider and importantly, the medical insurance industry. LFIRE(TM) is an enabling technology for more cost effective patient profiling of multiple tests for diagnosis, staging of disease and choice of targeted drug therapy, all key elements required for the medical industry's personalized medicine initiative. Most significantly, the market infrastructure for this technology already exists in the worldwide diagnostics and pharma industries and market penetration for this improved next generation, markedly cost effective, replacement measurement technology will be rapid. The Company is now planning development for the first commercial versions of LFIRE(TM), with planned market launch later in 2008.

http://www.mavenbiotech.com


'/>"/>
SOURCE Maven Biotechnologies, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Last week, ... for corporate executives and entrepreneurs, held The Future of San Diego Life Science event ... San Diego life science community attended the event with speakers Dr. Rich Heyman, former ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media ... in 2017 and Beyond. The paper outlines the key trends that are creating ... , “We’ve witnessed a lot of highs and lows as the precision agriculture ...
(Date:5/23/2016)... May 23, 2016 - Leading CRO,s Use ... - Frontage Implement a Single Platform to Manage End-to-end Operations ... Within the Bioanalytical lab Frontage Laboratories, a full-service contract ... and China , has selected IDBS, ... In addition to serving as the global electronic lab notebook (ELN), ...
(Date:5/22/2016)... ... , ... Doctors in Rome say micronutrients found in certain foods have the ... has just posted an article on the new research. Click here to read ... and Translational Medicine evaluated more than 150 studies on polyphenols in cancer for their ...
Breaking Biology Technology:
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/10/2016)... 10, 2016 --> ... report "Identity and Access Management Market by Component (Provisioning, ... Governance), by Organization Size, by Deployment, by Vertical, and ... MarketsandMarkets, The market is estimated to grow from USD ... 2020, at a Compound Annual Growth Rate (CAGR) of ...
(Date:3/9/2016)... , March 9, 2016 ... government identified that more than 23,000 public service employees ... had been receiving their salary unlawfully.    --> ... country,s government identified that more than 23,000 public service ... or had been receiving their salary unlawfully.    ...
Breaking Biology News(10 mins):